CDMO Profile

Delpharm

Delpharm Contract Manufacturing & Development (CDMO) Profile



Delpharm is a leading Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical industry, offering a wide range of drug development and manufacturing services. With 18 plants across multiple countries and a turnover exceeding 1 b…

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Biologics; Packaging; Food Supplements Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Semi-solids; Soft Gels; Solids; Sterile Ampoules; Sterile Vials Analytical Development; Formulation Development; ICH Stability Testing; Process Development Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; mRNA Vaccines; Protein Vaccines; Live Viral Vaccines; Viral Vector Vaccines; Plasmid DNA; Live Biotherapeutic Products

Year Founded: 1988

Head Office: Boulogne-Billancourt, France

Number of Facilities: More than 10

Facility locations: Europe; North America

Website: Visit the Delpharm website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.